Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong. It is developing various drugs that cover ophthalmic indications, including dry eye, myopia, presbyopia, wet age-related macular degeneration, diabetic macular edema, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People’s Republic of China.
Metrics to compare | 6622 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6622PeersSector | |
---|---|---|---|---|
P/E Ratio | −5.6x | −14.5x | −0.5x | |
PEG Ratio | −0.15 | 0.02 | 0.00 | |
Price/Book | 0.7x | 3.0x | 2.6x | |
Price / LTM Sales | 19.3x | 3.4x | 3.1x | |
Upside (Analyst Target) | −6.4% | 11.2% | 46.1% | |
Fair Value Upside | Unlock | −7.7% | 6.9% | Unlock |